Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Alzheimer Disease”

1,261 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,261 results

Testing effectiveness (Phase 2)Ended earlyNCT01561430
What this trial is testing

Study of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Eli Lilly and Company 70
Not applicableLooking for participantsNCT05468905
What this trial is testing

China Longitudinal Aging and Cognitive Impairment Study

Who this might be right for
AgingMild Cognitive ImpairmentAlzheimer Disease+1 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 4,000
Early research (Phase 1)Study completedNCT03113812
What this trial is testing

Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients

Who this might be right for
Alzheimer's Disease
Araclon Biotech S.L. 24
Early research (Phase 1)Study completedNCT02570997
What this trial is testing

Ascending Dose Study of CT1812 in Healthy Volunteers

Who this might be right for
Cognitive Impairment
Cognition Therapeutics 80
Large-scale testing (Phase 3)Study completedNCT01565382
What this trial is testing

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT03507790
What this trial is testing

Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.

Who this might be right for
Mild to Moderate Alzheimer's Disease
Cognition Therapeutics 153
Testing effectiveness (Phase 2)Ended earlyNCT00895895
What this trial is testing

Study Comparing 3 Dosage Levels Of SAM-531 In Outpatients With Mild To Moderate Alzheimer Disease

Who this might be right for
Alzheimer Disease
Pfizer 526
Large-scale testing (Phase 3)WithdrawnNCT00743743
What this trial is testing

Pilot Study of the Effects of Resveratrol Supplement in Mild-to-moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Medical College of Wisconsin
Not applicableNot Yet RecruitingNCT07230158
What this trial is testing

Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease II (TRANSFORM-AD II)

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 160
Testing effectiveness (Phase 2)Ended earlyNCT00334568
What this trial is testing

Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease

Who this might be right for
Alzheimer's Disease
GlaxoSmithKline 12
Post-approval studies (Phase 4)Study completedNCT00202124
What this trial is testing

Double Blind Study of Trp01 in Patients With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Queen's University 12
Testing effectiveness (Phase 2)Study completedNCT04032626
What this trial is testing

MCLENA-1: A Clinical Trial for the Assessment of Lenalidomide in Amnestic MCI Patients

Who this might be right for
Cognitive Impairment, MildCognitive DysfunctionAmyloid Plaque+2 more
St. Joseph's Hospital and Medical Center, Phoenix 15
Large-scale testing (Phase 3)WithdrawnNCT02317250
What this trial is testing

Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II

Who this might be right for
Mild Cognitive Impairment
University of California, Los Angeles
Testing effectiveness (Phase 2)Study completedNCT00566397
What this trial is testing

Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Pfizer 402
Large-scale testing (Phase 3)Study completedNCT02164643
What this trial is testing

Longitudinal Study of Brain Amyloid imaGing in MEMENTO

Who this might be right for
Alzheimer's Disease (AD) and Related Disorders
University Hospital, Bordeaux 448
Large-scale testing (Phase 3)Not Yet RecruitingNCT06797817
What this trial is testing

Tributyrin Treatment in Mild Alzheimer Disease: Assessment of Butyrate Effects Via the Gut-Brain

Who this might be right for
Alzheimer Disease (AD)
Universidad de Almeria 156
Not applicableStudy completedNCT03920826
What this trial is testing

Transcranial Alternating Current Stimulation for Patients With Mild Alzheimer's Disease (TRANSFORM-AD)

Who this might be right for
Alzheimer Disease
Xuanwu Hospital, Beijing 46
Testing effectiveness (Phase 2)UnknownNCT06185543
What this trial is testing

A Phase 2, Randomized, Prospective Double-Blind, Single-Center, Placebo-controlled Study to Evaluate Safety, Tolerability, Target Engagement, and Efficacy of PrimeC in Patients With Mild to Moderate Alzheimer's Disease.

Who this might be right for
Alzheimer Disease
NeuroSense Therapeutics Ltd. 20
Early research (Phase 1)Study completedNCT01548430
What this trial is testing

A Safety Study of TTP4000 in Subjects With Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
vTv Therapeutics 8
Not applicableWithdrawnNCT03514875
What this trial is testing

Effects of Mitochondrial-targeted Antioxidant on Mild Cognitive Impairment (MCI) Patients

Who this might be right for
Alzheimer Disease, Early OnsetMild Cognitive Impairment
University of Nebraska
Load More Results